John A. McCarty
22Patents
11h-index
9Co-inventors
68Inventor score
Filing activity: Nov 30, 1988 → Aug 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5912013A | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine | Human Necessities | 114 | Expired |
| US5073374A | Fast dissolving buccal tablet | Human Necessities | 114 | Expired |
| US5112616A | Fast dissolving buccal tablet | Human Necessities | 111 | Expired |
| US5430021A | Hydrophobic drug delivery systems | Human Necessities | 88 | Expired |
| US5484608A | Sustained-release drug delivery system | Human Necessities | 79 | Expired |
| US5447729A | Multilamellar drug delivery systems | Human Necessities | 65 | Expired |
| US5952004A | Emulsified drug delivery systems | Human Necessities | 43 | Expired |
| US8992974B2 | Transmucosal drug delivery system | Human Necessities | 37 | Active |
| US10172810B2 | Transmucosal ketamine delivery composition | Human Necessities | 31 | Active |
| US9358296B2 | Transmucosal drug delivery system | Human Necessities | 29 | Active |
| US5897876A | Emulsified drug delivery system | Human Necessities | 27 | Expired |
| US9549897B2 | Transmucosal hormone delivery system | Human Necessities | 8 | Active |
| US7230012B2 | Pharmaceutical compositions and dosage forms of thalidomide | Human Necessities | 8 | Expired |
| US8992948B2 | Melatonin tablet and methods of preparation and use | Human Necessities | 5 | Active |
| US9254294B2 | Transmucosal hormone delivery system | Human Necessities | 2 | Active |
| US9381190B2 | Melatonin tablet and methods of preparation and use | Human Necessities | 1 | Active |
| US9498454B2 | Transmucosal drug delivery system | Human Necessities | 1 | Active |
| US11786461B2 | Naloxone formulations for sublingual and/or buccal administration | Human Necessities | 0 | Active |
| US11077086B2 | Solid dosage form composition for buccal or sublingual administration of cannabinoids | Human Necessities | 0 | Active |
| US9006267B2 | Pharmaceutical compositions and dosage forms of thalidomide | Human Necessities | 0 | Active |
| US11129795B2 | Naloxone formulations for sublingual and/or buccal administration | Human Necessities | 0 | Active |
| US12303597B2 | Naloxone formulations for sublingual and/or buccal administration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.